PD-L1– and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease

570 Anti-Glomerular Basement Membrane Disease Injections, Subcutaneous 610 Autoimmunity CHO Cells Mouse models B7-H1 Antigen Arthritis, Rheumatoid 03 medical and health sciences Cricetulus 0302 clinical medicine Calcitriol Antigen presenting cells Immune Tolerance Animals Humans Antigen Presentation Immunodominant Epitopes Cell Differentiation Dendritic Cells HLA-DR Antigens Adoptive Transfer 3. Good health Disease Models, Animal 2700 Medicine Nephrology Liposomes Female Tolerance Immunologic Memory
DOI: 10.1172/jci.insight.126025 Publication Date: 2019-09-05T16:00:36Z
ABSTRACT
Autoimmune diseases resulting from MHC class II–restricted autoantigen-specific T cell immunity include the systemic inflammatory autoimmune conditions rheumatoid arthritis and vasculitis. While currently treated with broad-acting immunosuppressive drugs, a preferable strategy is to regulate antigen-specific effector cells (Teffs) restore tolerance by exploiting DC antigen presentation. We targeted draining lymph node (dLN) phagocytic DCs using liposomes encapsulating 1α,25-dihydroxyvitamin D3 (calcitriol) antigenic peptide elucidate mechanisms of used responding under resting immunized conditions. PD-L1 expression was upregulated in dLNs relative naive mice. Subcutaneous administration OVA323–339 calcitriol dLN PD-L1hi mice reduced their II expression. OVA323–339/calcitriol suppressed expansion, differentiation, function Teffs induced Foxp3+ IL-10+ peripheral Tregs an manner, which dependent on PD-L1. Peptide/calcitriol modulated CD40 human promoted Treg induction vitro. Liposomes disease-associated peptides severity Goodpasture's vasculitis models suppression memory differentiation function. Accordingly, peptide/calcitriol leverage for regulation induce diseases.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (70)
CITATIONS (54)